Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Blood

• Publication date

  2005-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD-2004-08-3168PMID 15687241PMCID PMC1895077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

  2004cited by this paper
• Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors*

  2004cited by this paper
• Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

  2004cited by this paper
• Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

  2003cited by this paper
• Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction.

  2003cited by this paper
• Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug‐resistant TCC in vitro

  2003cited by this paper
• Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.

  2003cited by this paper
• A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay.

  2003cited by this paper
• Elevated expression of inhibitor of apoptosis proteins in prostate cancer.

  2003cited by this paper
• Peptides Targeting Caspase Inhibitors*

  2003cited by this paper
• Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia

  2003cited by this paper
• Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.

  2003cited by this paper
• Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma.

  2002cited by this paper
• Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners.

  2002cited by this paper
• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• A matter of life and death.

  2002cited by this paper
• Characterization of XIAP-Deficient Mice

  2001cited by this paper
• Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

  2001cited by this paper
• Structural basis for the inhibition of caspase-3 by XIAP.

  2001cited by this paper
• X-linked Inhibitor of Apoptosis Protein (XIAP) Inhibits Caspase-3 and -7 in Distinct Modes*

  2001cited by this paper
• Proliferation, cell cycle and apoptosis in cancer

  2001cited by this paper
• NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP*

  2000cited by this paper
• Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death

  2000cited by this paper
• Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

  2000cited by this paper
• Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

  2000cited by this paper
• Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.

  2000cited by this paper
• Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

  2000cited by this paper
• Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

  1999cited by this paper
• Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner

  1999cited by this paper
• IAP family proteins--suppressors of apoptosis.

  1999cited by this paper
• Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade.

  1998cited by this paper
• IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases

  1998cited by this paper
• Proteases to die for.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• X-linked IAP is a direct inhibitor of cell-death proteases

  1997cited by this paper
• Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease.

  1997cited by this paper
• Detection of multiple antigens on western blots.

  1996cited by this paper
• Bcl-2 inhibits T-cell-mediated cytolysis of a leukemia cell line.

  1994cited by this paper
• Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.

  1994cited by this paper
• Immunohistochemical analysis of in vivo patterns of Bcl-X expression.

  1994cited by this paper
• Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

  1993cited by this paper
• Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.

  1987cited by this paper
• Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.

  1981cited by this paper
• A matter of life and death.

  1981cited by this paper
• Colony assay for proliferative blast cells circulating in myeloblastic leukaemia.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Identification, evolutionary and characteristic analysis of apoptosis - related caspase gene family in Tachysurus fulvidraco and their expression profiles under bacterial, parasitic, and viral infections.

  2025cites this paper
• Palbociclib as an Antitumor Drug: A License to Kill

  2024cites this paper
• Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations

  2024cites this paper
• Hesperidin/Salinomycin Combination; a Natural Product for Deactivation of the PI3K/Akt Signaling Pathway and Anti-Apoptotic Factors in KG1a Cells

  2024cites this paper
• Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia

  2023cites this paper
• Targeting regulated cell death pathways in acute myeloid leukemia

  2023cites this paper
• 1,5-Disubstituted Acylated 2-Amino-4,5-dihydroimidazoles as a New Class of Retinoic Acid Receptor–Related Orphan Receptor (ROR) Inhibitors

  2022cites this paper
• Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines

  2021cites this paper
• Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression

  2021cites this paper
• Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia

  2021cites this paper
• Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists

  2020cites this paper
• The study of cellular mechanism of triptolide in the treatment of cancer, bone loss and cardiovascular disease and triptolide's toxicity.

  2019cites this paper
• The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia.

  2018cites this paper
• Protein network related to unfavorable prognosis in Acute Myeloid Leukemia

  2017cites this paper
• Therapeutic opportunities based on caspase modulation.

  2017cites this paper
• Smac Mimetics to Therapeutically Target IAP Proteins in Cancer.

  2017cites this paper
• New Frontiers in Cancer Chemotherapy — Targeting Cell Death Pathways

  2016cites this paper
• Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas

  2015cites this paper
• Smac mimetics as IAP antagonists.

  2015cites this paper
• IAP Family of Proteins as Therapeutic Targets for Acute Myeloid Leukemia

  2015cites this paper
• Could the eIF2α-Independent Translation Be the Achilles Heel of Cancer?

  2015cites this paper
• Targeting AML stem/progenitor cells by combinational therapy with SMAC mimetics and demethylating agents

  2015cites this paper
• In Silico Designing and Screening of Antagonists against Cancer Drug Target XIAP.

  2015cites this paper
• Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.

  2015cites this paper
• Apoptosis repressor with caspase recruitment domain modulates second mitochondrial‐derived activator of caspases mimetic‐induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia

  2014cites this paper
• Small molecule modulators of protein-protein interactions: selected case studies.

  2014cites this paper
• Synergistic interaction of Smac mimetic and IFNα to trigger apoptosis in acute myeloid leukemia cells.

  2014cites this paper
• The atherogenic effects of serum amyloid A are potentially mediated via inflammation and apoptosis.

  2014cites this paper
• Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.

  2014cites this paper
• treatment of leukemia and multiple myeloma The ubiquitin-activating enzyme E1 as a therapeutic target for the

  2013cites this paper
• Molecular Pathways: Targeting Inhibitor of Apoptosis Proteins in Cancer—From Molecular Mechanism to Therapeutic Application

  2013cites this paper
• Targeting apoptosis proteins in hematological malignancies.

  2013cites this paper
• Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis

  2013cites this paper
• XIAP antisense therapy with AEG 35156 in acute myeloid leukemia

  2013cites this paper
• AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation.

  2013cites this paper
• Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies

  2012cites this paper
• The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac.

  2012cites this paper
• A genome wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance

  2012cites this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cites this paper
• XIAP-positive diffuse large B-cell lymphoma cells Small-molecule XIAP antagonist restores caspase-9-mediated apoptosis in

  2012cites this paper
• followed by cytosine arabinoside and mitoxantrone for acute leukemias Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol

  2012cites this paper
• Molecular analysis of the domain with no name (DWNN)/RBBP6 in human cancers

  2012cites this paper
• Synthesis of Chalcones with Anticancer Activities

  2012cites this paper
• Abstract A22: A genome-wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance.

  2011cites this paper
• Promising Targeted Agents

  2011cites this paper
• , 3-kinase pathway preclinical efficacy in myeloma and leukemia via phosphoinositide A small-molecule inhibitor of D-cyclin transactivation displays

  2011cites this paper
• Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.

  2011cites this paper
• Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis

  2011cites this paper
• A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway.

  2011cites this paper
• ARTS-based anticancer therapy: taking aim at cancer stem cells.

  2011cites this paper
• Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.

  2011cites this paper
• Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.

  2011cites this paper
• Inhibition of SREBP1 sensitizes cells to death ligands

  2011cites this paper
• IRES-mediated translation of cellular messenger RNA operates in eIF2α- independent manner during stress

  2011cites this paper
• Effect of noncompetitive proteasome inhibition on bortezomib resistance.

  2010cites this paper
• e ffect of Noncompetitive Proteasome i nhibition on Bortezomib r esistance

  2010cites this paper
• The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.

  2010cites this paper
• Exploiting cellular pathways to develop new treatment strategies for AML.

  2010cites this paper
• Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.

  2010cites this paper
• Inhibition of Akt / GSK 3 β signalling pathway by Legionella pneumophila is involved in induction of T-cell apoptosis

  2010cites this paper
• The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma.

  2010cites this paper
• XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML

  2010cites this paper
• Inhibition of Akt/GSK3beta signalling pathway by Legionella pneumophila is involved in induction of T-cell apoptosis.

  2010cites this paper
• Apoptosis in leukemias: regulation and therapeutic targeting.

  2010cites this paper
• Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.

  2009cites this paper
• Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.

  2009cites this paper
• A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC

  2009cites this paper
• Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia

  2009cites this paper
• Apoptosis and cancer: mutations within caspase genes

  2009cites this paper
• Inhibitor of apoptosis proteins in hematological malignancies

  2009cites this paper
• Overcoming drug resistance by enhancing apoptosis of tumor cells.

  2009cites this paper
• Cell death in hematological tumors

  2009cites this paper
• Targeting apoptosis as an approach for gastrointestinal cancer therapy.

  2009cites this paper
• Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95‐induced apoptosis

  2009cites this paper
• Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.

  2009cites this paper
• Apoptosis in Cancer Biology and Cancer Therapeutics

  2009cites this paper
• Fully phosphorothioated second-generation 19-mer mixed-backbone antisense oligonucleotide (ASO) consisting of an 11-nucleotide DNA core flanked at the 3' and 5' ends by four 2'-O-methyl RNA residues, targeting the X-linked inhibitor of apoptosis protein (XIAP)

  2009cites this paper
• Die TRAIL-Suszeptibilität humaner Melanomzellen : Bedeutung des Tumorprogressionsstadiums und Modulation durch Immunsuppressiva

  2009cites this paper
• Apoptosis and cancer : mutations within caspase genes

  2009cites this paper
• SHORT REPORT Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo

  2008cites this paper
• IAPs as therapeutic targets in haematological malignancies

  2008cites this paper
• Therapeutic targeting of apoptosis pathways in cancer

  2008cites this paper
• Chemical biology--understanding biology and advancing therapy.

  2008cites this paper
• Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor γ ligand-induced growth inhibition in colon cancer

  2008cites this paper
• Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.

  2008cites this paper
• Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.

  2008cites this paper
• Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo

  2008cites this paper
• The Cys-Asn-Ser carboxyl-terminal end group is the pharmacophore of the amebic anti-inflammatory monocyte locomotion inhibitory factor (MLIF).

  2008cites this paper
• A novel diquinolonium displays preclinical anti-cancer activity and induces caspase-independent cell death

  2008cites this paper
• Regulation of apoptosis by XIAP ubiquitin-ligase activity.

  2008cites this paper
• Cyproheptadine displays preclinical activity in myeloma and leukemia.

  2008cites this paper
• IAP-targeted therapies for cancer

  2008cites this paper
• Molecular targeting of E3 ligases – a therapeutic approach for cancer

  2008cites this paper
• Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy.

  2008cites this paper
• Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.

  2008cites this paper
• A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization

  2008cites this paper
• Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance.

  2008cites this paper
• Caspases: structure-guided design of drugs to control cell death.

  2008cites this paper
• Apoptosis in leukemia: from molecular pathways to targeted therapies.

  2008cites this paper
• Quantitative analysis of the receptor-induced apoptotic decision network

  2008cites this paper